Investor Alert

London Markets Open in:

Company Close Updates Archives | Email alerts

Dec. 4, 2020, 5:07 p.m. EST

Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

Shares of Corbus Pharmaceuticals Holdings Inc. CRBP rose 6.77% to $1.42 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.70% to 12,464.23 and the Dow Jones Industrial Average DJIA rising 0.83% to 30,218.26. Corbus Pharmaceuticals Holdings Inc. closed $8.36 short of its 52-week high ($9.78), which the company reached on August 31st.

The stock outperformed some of its competitors Friday, as Fate Therapeutics Inc. FATE rose 0.61% to $60.79, Vanda Pharmaceuticals Inc. VNDA rose 2.06% to $13.35, and Viking Therapeutics Inc. VKTX rose 0.48% to $6.33. Trading volume (4.7 M) remained 7,103 below its 50-day average volume of 4.7 M.

Editor's Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.